Voso MT - Search Results

1

Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects.

Leone G, Sica S, Voso MT, Rutella S, Pagano L. Leone G, et al. Among authors: voso mt. Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):33-52. doi: 10.2174/187152506775268820. Cardiovasc Hematol Agents Med Chem. 2006. PMID: 16529548 Review.

2

Hepato-splenic mycotic abscesses in patients with acute leukemia.

Marra R, Pagano L, Storti S, Voso MT, Sica S, Di Mario A, Danza F, Leone G. Marra R, et al. Among authors: voso mt. Leuk Lymphoma. 1992 Aug;7(5-6):517-9. doi: 10.3109/10428199209049810. Leuk Lymphoma. 1992. PMID: 1493451 No abstract available.

3

Oral idarubicin plus cytosine arabinoside in the treatment of acute non lymphoblastic leukemia in elderly patients.

Pagano L, Sica S, Marra R, Voso MT, Storti S, Di Mario A, Leone G. Pagano L, et al. Among authors: voso mt. Haematologica. 1991 Nov-Dec;76(6):517-8. Haematologica. 1991. PMID: 1820991 Clinical Trial.

4

Salvage chemotherapy with pentostatin in prolymphocytic leukemia.

Pagano L, Ortu-La Barbera EO, Voso MT, Zollino M, Laurenti L, Marra R, Leone G. Pagano L, et al. Among authors: voso mt. Haematologica. 1994 Nov-Dec;79(6):542-5. Haematologica. 1994. PMID: 7896214

5

Prevalence of obesity in young adults with acute lymphoblastic leukemia.

Pagano L, De Rosa G, Voso MT, Marra R, Testa A, Leone G. Pagano L, et al. Among authors: voso mt. Int J Clin Lab Res. 1994;24(2):117-9. doi: 10.1007/BF02593912. Int J Clin Lab Res. 1994. PMID: 7919428

6

Granuloblastic masses in the breast: report of two cases.

Pagano L, Voso MT, La Rocca LM, Marra R, Leone G. Pagano L, et al. Among authors: voso mt. Haematologia (Budap). 1993;25(4):287-91. Haematologia (Budap). 1993. PMID: 8157212

7

Recovery from diabetes insipidus associated with AML after a BMT conditioning regimen including busulfan.

Pagano L, Voso MT, Sica S, Leone G. Pagano L, et al. Among authors: voso mt. Bone Marrow Transplant. 1993 Feb;11(2):175-6. Bone Marrow Transplant. 1993. PMID: 8435667

8

RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.

Rumi C, Rutella S, Teofili L, Etuk B, Ortu La Barbera E, Micciulli G, Voso MT, Leone G. Rumi C, et al. Among authors: voso mt. Exp Hematol. 1997 Mar;25(3):246-51. Exp Hematol. 1997. PMID: 9091301

9

Telomerase activity in human hematopoietic progenitor cells.

Hohaus S, Voso MT, Orta-La Barbera E, Cavallo S, Bellacosa A, Rutella S, Rumi C, Genuardi M, Neri G, Leone G. Hohaus S, et al. Among authors: voso mt. Haematologica. 1997 May-Jun;82(3):262-8. Haematologica. 1997. PMID: 9234570

10

Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70.

Larocca LM, Ranelletti FO, Maggiano N, Rutella S, La Barbera EO, Rumi C, Serra F, Voso MT, Piantelli M, Teofili L, Leone G. Larocca LM, et al. Among authors: voso mt. Int J Cancer. 1997 Sep 26;73(1):75-83. doi: 10.1002/(sici)1097-0215(19970926)73:1<75::aid-ijc13>3.0.co;2-4. Int J Cancer. 1997. PMID: 9334813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters